Prime Medicine, Inc. (NASDAQ:PRME) ranks among the overlooked penny stocks to buy right now, supported by strong upside ...

Explore the revolutionary potential of biotechnology and gene editing, alongside crucial ethical considerations and ...

Editorial: Polling shows that the public supports this new technology, but the conversation must move beyond simple questions of safety ...

A Surrey family is racing against time to raise enough money for a gene-editing procedure that could save their ...

A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...

The report – ‘Fertility, Embryo Research and Genome Editing: Public Attitudes in Europe’, commissioned by the charity Progress Educational Trust (PET), supported by ESHRE and conducted by Ipso, was ...

A Russian cultural centre in Moldova, ordered closed by the pro-European government, shut its doors on Saturday after more than 15 years, with Russian ​officials expressing hope that they could still ...

Engineering Our Future, Questioning Our Conscience reflects on technology, ethics and responsibility, examining how ...

Casgevy sickle cell gene therapy is now FDA-approved for children as young as two, opening access for 5,500 more U.S. kids.

Recent data published in NEJM demonstrates that CRISPR gene-editing therapy achieves complete clinical efficacy endpoints in ...

New licensing rules for stem cell and gene therapies in India aim to enhance safety but won't immediately reduce costs or ...

The 18th Straits Forum was held on June 13 in Xiamen, Fujian, China. At the forum, three Taiwanese youths from different ...